Skip to main content

Digoxin

NDC 10135-747 · Marlex Pharmaceuticals, Inc.

Generic nameDigoxin
Dosage formTABLET
RouteORAL
Active ingredient(s)DIGOXIN
Strength.125 mg/1
Pharmacologic classCardiac Glycoside [EPC], Cardiac Glycosides [CS]
Marketing categoryANDA

Packages

10135-747-01 — 100 TABLET in 1 BOTTLE (10135-747-01)

10135-747-10 — 1000 TABLET in 1 BOTTLE (10135-747-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0115-9822 — DIGOXIN, 0143-1240 — Digoxin, 0143-1241 — Digoxin, 0404-9850 — Digoxin, 0615-8202 — Digoxin, 0641-1410 — Digoxin, 0641-6184 — Digoxin, 0781-3059 — Digoxin, 0904-5921 — Digoxin, 0904-5922 — Digoxin, 10135-748 — Digoxin, 17856-0057 — Digoxin, 50090-5642 — Digoxin, 50090-5862 — Digoxin, 50090-6588 — Digoxin, 50090-6708 — Digoxin, 50090-7865 — Digoxin, 50268-238 — Digoxin, 51655-403 — Digoxin, 51662-1217 — DIGOXIN, +39 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources